Abstract
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have